OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 9.1
Unit: Percentage (%)
CFR/IFR numerator: 119
CFR/IFR denominator: 1312
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 74
Sample size: 1312
Country: Hong Kong SAR,  China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 4.4
Unit: Days
Uncertainty single value: 2.7 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2.7 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 74
Sample size: 1312
Country: Hong Kong SAR,  China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Unit: No units
Value type: Unspecified
Uncertainty type: 95% CrI
Epidemic phase: End outbreak
Reproduction number method: Other
Reproduction number pathway: Human-human
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Unspecified
Sex: Unspecified
Sample size: 1755
Country: Hong Kong SAR,  China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 3.96
Unit: Days
Value type: Mean
Uncertainty single value: 4.28 (Standard deviation (Sd) [Sample])
Combined uncertainty: 4.28 (Standard deviation (Sd) [Sample])
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Sample size: 5327
Country: China
Study period:  Nov 11 2002 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>discharge/recovery
Parameter value: 25.19
Unit: Days
Value type: Mean
Uncertainty single value: 22.43 (Standard deviation (Sd) [Sample])
Combined uncertainty: 22.43 (Standard deviation (Sd) [Sample])
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Study period:  Nov 11 2002 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5.29
Unit: Days
Value type: Mean
Lower bound: 2.93
Upper bound: 7.17
Bounds: 2.93 - 7.17
Uncertainty single value: 12.33 (Variance)
Combined uncertainty: 12.33 (Variance)
Disaggregated by: Age, Occupation, Other, Region, Sex
Population group: Persons under investigation
Sample type: Mixed settings
Sex: Both
Sample size: 209
Country: China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Mixed settings
Sex: Both
Sample size: 350
Country: China
Location: Mainland China (22 provinces) overall, Hebei Province, Inner Mongolia
Study period: 1 Jan 01 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Mixed settings
Sex: Both
Sample size: 350
Country: China
Location: Mainland China (22 provinces) overall, Hebei Province, Inner Mongolia
Study period: 1 Jan 01 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Disaggregated by: Region
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Mixed settings
Sex: Both
Sample size: 350
Country: China
Location: Mainland China (22 provinces) overall, Hebei Province, Inner Mongolia
Study period: 1 Jan 01 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Disaggregated by: Region
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Mixed settings
Sex: Both
Sample size: 350
Country: China
Location: Mainland China (22 provinces) overall, Hebei Province, Inner Mongolia
Study period: 1 Jan 01 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 84.8
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 28
CFR/IFR denominator: 33
CFR/IFR method: Naive
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 23
Maximum age: 86
Sample size: 33
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 20 Mar 03 2003 to 5 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 24.9
Unit: Days
Value type: Mean
Lower bound: 19.8
Upper bound: 39.3
Bounds: 19.8 - 39.3
Uncertainty type: Inter Quartile Range (IQR) [Sample]
Uncertainty lower value: 14.8
Uncertainty upper value: 33.3
Combined uncertainty: 14.8 - 33.3 (Inter Quartile Range (IQR) [Sample])
Disaggregated by: Disease generation
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 23
Maximum age: 86
Sample size: 67
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 20 Mar 03 2003 to 5 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 31.3
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 21
CFR/IFR denominator: 67
CFR/IFR method: Naive
Disaggregated by: Disease generation
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 23
Maximum age: 86
Sample size: 67
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 20 Mar 03 2003 to 5 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 4.6
Unit: Days
Value type: Mean
Uncertainty type: Range [Sample]
Uncertainty lower value: 1
Uncertainty upper value: 13
Uncertainty single value: 6.8 (Standard Deviation)
Combined uncertainty: 1 - 13 (Range [Sample])
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 23
Maximum age: 86
Sample size: 17
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 20 Mar 03 2003 to 5 Jul 07 2003
Other delay start: Symptom Onset/Fever
Other delay end: Abnormal radiograph
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Cormobidity;Other;Sex
Risk factor outcome: Severe disease
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 23
Maximum age: 86
Sample size: 67
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 20 Mar 03 2003 to 5 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Severe disease
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 23
Maximum age: 86
Sample size: 67
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 20 Mar 03 2003 to 5 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Cormobidity;Other
Risk factor outcome: Severe disease
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 23
Maximum age: 86
Sample size: 67
Country: Taiwan,  China
Location: Taipei Veterans General Hospital
Study period: 20 Mar 03 2003 to 5 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 12
Unit: Percentage (%)
CFR/IFR numerator: 24
CFR/IFR denominator: 201
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 201
Country: Hong Kong SAR,  China
Study period: 26 Feb 02 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Age;Cormobidity;Other;Sex
Risk factor outcome: Severe disease
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 201
Country: Hong Kong SAR,  China
Study period: 26 Feb 02 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Severe disease
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 201
Country: Hong Kong SAR,  China
Study period: 26 Feb 02 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IFA
Parameter value: 4.7
Unit: Percentage (%)
CFR/IFR numerator: 9
CFR/IFR denominator: 193
Epidemic phase: Post outbreak
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Sample size: 193
Country: Taiwan,  China
Location: National
Taiwan University Hospital (NTUH)
Study period: 30 Mar 03 2003 to 30 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Unit: Days
Lower bound: 2
Upper bound: 10
Bounds: 2 - 10
Epidemic phase: Post outbreak
Population group: Children
Sample type: Population based
Sex: Both
Minimum age: 4
Maximum age: 20
Sample size: 15
Country: Taiwan,  China
Study period:  Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 21.1
Unit: Percentage (%)
CFR/IFR numerator: 73
CFR/IFR denominator: 346
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: General population
Sample type: Population based
Sex: Both
Sample size: 346
Country: Taiwan,  China
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 6
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 3
Uncertainty upper value: 10
Combined uncertainty: 3 - 10 (IQR)
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 144
Country: Canada
Location: Toronto
Study period: 7 Mar 03 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 3
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 2
Uncertainty upper value: 5
Combined uncertainty: 2 - 5 (IQR)
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 144
Country: Canada
Location: Toronto
Study period: 7 Mar 03 2003 to 10 Apr 04 2003
Other delay start: Seeking Care
Other delay end: Admission to Care/Hospitalisation
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 10
Unit: Days
Value type: Median
Uncertainty type: IQR
Uncertainty lower value: 6
Uncertainty upper value: 15
Combined uncertainty: 6 - 15 (IQR)
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 144
Country: Canada
Location: Toronto
Study period: 7 Mar 03 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Cormobidity;Other;Sex
Risk factor outcome: Severe disease
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 144
Country: Canada
Location: Toronto
Study period: 7 Mar 03 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other
Risk factor outcome: Severe disease
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 144
Country: Canada
Location: Toronto
Study period: 7 Mar 03 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Cormobidity
Risk factor outcome: Severe disease
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 144
Country: Canada
Location: Toronto
Study period: 7 Mar 03 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age
Risk factor outcome: Severe disease
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 144
Country: Canada
Location: Toronto
Study period: 7 Mar 03 2003 to 10 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - latent period
Parameter value: 4.49
Unit: Days
Value type: Mean
Uncertainty single value: 2.63 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2.63 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: China
Location: Guangdong, Beijing
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - infectious period
Parameter value: 12.5
Unit: Days
Value type: Mean
Uncertainty single value: 5.6 (Standard deviation (Sd) [Sample])
Combined uncertainty: 5.6 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 2.89
Unit: Days
Value type: Mean
Uncertainty single value: 2.1 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2.1 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>discharge/recovery
Parameter value: 23.1
Unit: Days
Value type: Mean
Uncertainty single value: 7.8 (Standard deviation (Sd) [Sample])
Combined uncertainty: 7.8 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>death
Parameter value: 23.5
Unit: Days
Value type: Mean
Uncertainty single value: 13.2 (Standard deviation (Sd) [Sample])
Combined uncertainty: 13.2 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Unit: No units
Lower bound: 0
Upper bound: 6
Bounds: 0 - 6
Epidemic phase: Post outbreak
Reproduction number method: Compartmental model
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Sample size: 671
Country: Taiwan,  China
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4
Unit: Days
Value type: Mean
Uncertainty single value: 3 (Standard deviation (Sd) [Sample])
Combined uncertainty: 3 (Standard deviation (Sd) [Sample])
Epidemic phase: Mid outbreak
Disaggregated by: Age, Sex
Population group: Healthcare workers
Sample type: Hospital based
Sex: Female
Minimum age: 38
Maximum age: 53
Sample size: 4
Country: Canada
Location: Toronto
Study period: 23 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 3.5
Unit: Days
Value type: Mean
Uncertainty single value: 3 (Standard deviation (Sd) [Sample])
Combined uncertainty: 3 (Standard deviation (Sd) [Sample])
Epidemic phase: Mid outbreak
Disaggregated by: Age, Sex
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 27
Maximum age: 63
Sample size: 10
Country: Canada
Location: Toronto
Study period: 23 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 4.6
Unit: Days
Value type: Mean
Uncertainty type: Range [Sample]
Uncertainty lower value: 1
Uncertainty upper value: 8
Uncertainty single value: 2 (Standard deviation (Sd) [Sample])
Combined uncertainty: 1 - 8 (Range [Sample])
Epidemic phase: Mid outbreak
Disaggregated by: Age, Sex
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 27
Maximum age: 63
Sample size: 14
Country: Canada
Location: Toronto
Study period: 23 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - time in care (length of stay)
Parameter value: 14
Unit: Days
Value type: Mean
Uncertainty type: Range [Sample]
Uncertainty lower value: 12
Uncertainty upper value: 15
Combined uncertainty: 12 - 15 (Range [Sample])
Epidemic phase: Mid outbreak
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 27
Maximum age: 63
Sample size: 14
Country: Canada
Location: Toronto
Study period: 23 Mar 03 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 1
Maximum age: 98
Sample size: 1373
Country: Hong Kong SAR,  China
Study period:  Mar 03 2003 to  Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 11.8
Unit: Percentage (%)
CFR/IFR numerator: 172
CFR/IFR denominator: 1462
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: General population
Sample type: Population based
Sex: Both
Minimum age: 1
Maximum age: 98
Sample size: 1462
Country: Hong Kong SAR,  China
Study period:  Mar 03 2003 to  Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 1
Maximum age: 98
Sample size: 1373
Country: Hong Kong SAR,  China
Study period:  Mar 03 2003 to  Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Mutations
Parameter type: Mutations – mutation rate
Parameter value: 8.26
Unit: Unspecified
Value type: Unspecified
Uncertainty single value: 2.16 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2.16 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Sample size: 61
Country: China
Study period: 31 Jan 01 2003 to
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Unit: No units
Value type: Unspecified
Lower bound: 1.5402
Upper bound: 5.6304
Bounds: 1.5402 - 5.6304
Epidemic phase: Unspecified
Reproduction number method: Growth rate
Reproduction number pathway: Human-human
Disaggregated by: Region
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: China, Hong Kong SAR,  China, Singapore, Taiwan,  China
Location: Mainland China, Beijing, Hebei, Tianjin, Shanxi, Inner Mongolia, Hong Kong, Taiwan, Singapore
Pathogen: SARS-CoV
Parameter class: Growth rate
Parameter type: Growth rate (r)
Unit: Percentage (%)
Value type: Unspecified
Epidemic phase: Unspecified
Disaggregated by: Region
Population group: Unspecified
Sample type: Unspecified
Sex: Unspecified
Country: China, Hong Kong SAR,  China, Singapore
Location: Beijing, Hong Kong, Singapore
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Unit: No units
Value type: Unspecified
Lower bound: 1.4937
Upper bound: 0.2485
Bounds: 1.4937 - 0.2485
Epidemic phase: Unspecified
Reproduction number method: Growth rate
Reproduction number pathway: Human-human
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Mainland (China)
Study period: 21 Apr 04 2003 to 12 May 05 2003
Pathogen: SARS-CoV
Parameter class: Growth rate
Parameter type: Growth rate (r)
Unit: No units
Value type: Unspecified
Lower bound: 0.013
Upper bound: 0.0713
Bounds: 0.013 - 0.0713
Epidemic phase: Unspecified
Reproduction number method: Growth rate
Reproduction number pathway: Human-human
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Mainland (China)
Study period: 21 Apr 04 2003 to 12 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Unit: Percentage (%)
Lower bound: 15
Upper bound: 20
Bounds: 15 - 20
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 1755
Country: Hong Kong SAR,  China
Study period:  Apr 04 2003 to 31 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Unit: Percentage (%)
Lower bound: 15
Upper bound: 19
Bounds: 15 - 19
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Hospital based
Sample size: 238
Country: Singapore
Study period:  Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Basic R0)
Parameter value: 2.16
Unit: No units
Value type: Unspecified
Epidemic phase: Post outbreak
Reproduction number method: Compartmental model
Reproduction number pathway: Human-human
Population group: General population
Sample type: Population based
Sex: Unspecified
Country: China
Location: Beijing
Study period: 21 Apr 04 2003 to 24 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Close contact;Other
Risk factor outcome: Superspreading
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 127
Country: China
Location: Guangzhou, Hong Kong
Study period:  Sep 09 2004 to  Nov 11 2005
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Superspreading
Risk factor occupation: Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 127
Country: China
Location: Guangzhou, Hong Kong
Study period:  Sep 09 2004 to  Nov 11 2005